Logo image of IRM

IRON MOUNTAIN INC (IRM) Stock Fundamental Analysis

NYSE:IRM - New York Stock Exchange, Inc. - US46284V1017 - REIT - Currency: USD

98.9  -1.03 (-1.03%)

Fundamental Rating

3

IRM gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 30 industry peers in the Specialized REITs industry. There are concerns on the financial health of IRM while its profitability can be described as average. IRM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

IRM had positive earnings in the past year.
In the past year IRM had a positive cash flow from operations.
IRM had positive earnings in each of the past 5 years.
IRM had a positive operating cash flow in each of the past 5 years.
IRM Yearly Net Income VS EBIT VS OCF VS FCFIRM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

With a Return On Assets value of 0.63%, IRM is not doing good in the industry: 70.00% of the companies in the same industry are doing better.
IRM has a Return On Invested Capital of 5.91%. This is in the better half of the industry: IRM outperforms 66.67% of its industry peers.
IRM had an Average Return On Invested Capital over the past 3 years of 5.88%. This is in line with the industry average of 5.28%.
The 3 year average ROIC (5.88%) for IRM is below the current ROIC(5.91%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.63%
ROE N/A
ROIC 5.91%
ROA(3y)1.82%
ROA(5y)2.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.88%
ROIC(5y)5.9%
IRM Yearly ROA, ROE, ROICIRM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

1.3 Margins

IRM has a worse Profit Margin (1.95%) than 70.00% of its industry peers.
IRM's Profit Margin has declined in the last couple of years.
IRM's Operating Margin of 19.77% is on the low side compared to the rest of the industry. IRM is outperformed by 73.33% of its industry peers.
In the last couple of years the Operating Margin of IRM has grown nicely.
IRM's Gross Margin of 66.98% is on the low side compared to the rest of the industry. IRM is outperformed by 60.00% of its industry peers.
IRM's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 19.77%
PM (TTM) 1.95%
GM 66.98%
OM growth 3Y-0.58%
OM growth 5Y1.53%
PM growth 3Y-33.64%
PM growth 5Y-14.13%
GM growth 3Y-1.38%
GM growth 5Y3.37%
IRM Yearly Profit, Operating, Gross MarginsIRM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), IRM is destroying value.
IRM has more shares outstanding than it did 1 year ago.
IRM has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, IRM has a worse debt to assets ratio.
IRM Yearly Shares OutstandingIRM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
IRM Yearly Total Debt VS Total AssetsIRM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

IRM has an Altman-Z score of 1.00. This is a bad value and indicates that IRM is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.00, IRM is in line with its industry, outperforming 50.00% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z 1
ROIC/WACC0.74
WACC7.93%
IRM Yearly LT Debt VS Equity VS FCFIRM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

A Current Ratio of 0.62 indicates that IRM may have some problems paying its short term obligations.
With a Current ratio value of 0.62, IRM perfoms like the industry average, outperforming 56.67% of the companies in the same industry.
IRM has a Quick Ratio of 0.62. This is a bad value and indicates that IRM is not financially healthy enough and could expect problems in meeting its short term obligations.
IRM has a Quick ratio (0.62) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.62
IRM Yearly Current Assets VS Current LiabilitesIRM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

4

3. Growth

3.1 Past

IRM shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -0.56%.
Measured over the past years, IRM shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.69% on average per year.
IRM shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 11.04%.
IRM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.61% yearly.
EPS 1Y (TTM)-0.56%
EPS 3Y5.37%
EPS 5Y11.69%
EPS Q2Q%0%
Revenue 1Y (TTM)11.04%
Revenue growth 3Y11.04%
Revenue growth 5Y7.61%
Sales Q2Q%7.83%

3.2 Future

Based on estimates for the next years, IRM will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.74% on average per year.
The Revenue is expected to grow by 7.68% on average over the next years.
EPS Next Y15.39%
EPS Next 2Y14.73%
EPS Next 3Y13.74%
EPS Next 5YN/A
Revenue Next Year10.57%
Revenue Next 2Y9.78%
Revenue Next 3Y8.96%
Revenue Next 5Y7.68%

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
IRM Yearly Revenue VS EstimatesIRM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B
IRM Yearly EPS VS EstimatesIRM Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.5 1 1.5 2 2.5

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 55.25, IRM can be considered very expensive at the moment.
IRM's Price/Earnings ratio is in line with the industry average.
IRM's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.21.
With a Price/Forward Earnings ratio of 41.97, IRM can be considered very expensive at the moment.
IRM's Price/Forward Earnings ratio is in line with the industry average.
IRM's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 21.70.
Industry RankSector Rank
PE 55.25
Fwd PE 41.97
IRM Price Earnings VS Forward Price EarningsIRM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

70.00% of the companies in the same industry are cheaper than IRM, based on the Enterprise Value to EBITDA ratio.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.52
IRM Per share dataIRM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 -20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates IRM does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as IRM's earnings are expected to grow with 13.74% in the coming years.
PEG (NY)3.59
PEG (5Y)4.73
EPS Next 2Y14.73%
EPS Next 3Y13.74%

5

5. Dividend

5.1 Amount

IRM has a Yearly Dividend Yield of 3.11%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 5.88, IRM is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.42, IRM pays a bit more dividend than the S&P500 average.
Industry RankSector Rank
Dividend Yield 3.11%

5.2 History

The dividend of IRM has a limited annual growth rate of 1.86%.
IRM has paid a dividend for at least 10 years, which is a reliable track record.
IRM has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)1.86%
Div Incr Years2
Div Non Decr Years11
IRM Yearly Dividends per shareIRM Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

IRM pays out 667.77% of its income as dividend. This is not a sustainable payout ratio.
The dividend of IRM is growing, but earnings are growing more, so the dividend growth is sustainable.
DP667.77%
EPS Next 2Y14.73%
EPS Next 3Y13.74%
IRM Yearly Income VS Free CF VS DividendIRM Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M
IRM Dividend Payout.IRM Dividend Payout, showing the Payout Ratio.IRM Dividend Payout.PayoutRetained Earnings

IRON MOUNTAIN INC

NYSE:IRM (7/2/2025, 11:39:50 AM)

98.9

-1.03 (-1.03%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustrySpecialized REITs
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners84.34%
Inst Owner Change0.96%
Ins Owners0.68%
Ins Owner Change-4.34%
Market Cap29.17B
Analysts77.14
Price Target118.7 (20.02%)
Short Float %3.58%
Short Ratio6.28
Dividend
Industry RankSector Rank
Dividend Yield 3.11%
Yearly Dividend2.7
Dividend Growth(5Y)1.86%
DP667.77%
Div Incr Years2
Div Non Decr Years11
Ex-Date06-16 2025-06-16 (0.785)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.93%
Min EPS beat(2)-9.85%
Max EPS beat(2)5.99%
EPS beat(4)1
Avg EPS beat(4)-4.62%
Min EPS beat(4)-9.99%
Max EPS beat(4)5.99%
EPS beat(8)4
Avg EPS beat(8)-0.59%
EPS beat(12)7
Avg EPS beat(12)2.66%
EPS beat(16)10
Avg EPS beat(16)2.91%
Revenue beat(2)0
Avg Revenue beat(2)-1.65%
Min Revenue beat(2)-2.21%
Max Revenue beat(2)-1.09%
Revenue beat(4)1
Avg Revenue beat(4)-0.77%
Min Revenue beat(4)-2.21%
Max Revenue beat(4)0.95%
Revenue beat(8)2
Avg Revenue beat(8)-1.11%
Revenue beat(12)2
Avg Revenue beat(12)-1.58%
Revenue beat(16)4
Avg Revenue beat(16)-1.16%
PT rev (1m)0.32%
PT rev (3m)-1.73%
EPS NQ rev (1m)0%
EPS NQ rev (3m)13.64%
EPS NY rev (1m)-2.53%
EPS NY rev (3m)7.35%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.13%
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)1.61%
Valuation
Industry RankSector Rank
PE 55.25
Fwd PE 41.97
P/S 4.66
P/FCF N/A
P/OCF 23.08
P/B N/A
P/tB N/A
EV/EBITDA 20.52
EPS(TTM)1.79
EY1.81%
EPS(NY)2.36
Fwd EY2.38%
FCF(TTM)-3.02
FCFYN/A
OCF(TTM)4.29
OCFY4.33%
SpS21.24
BVpS-2.37
TBVpS-24.1
PEG (NY)3.59
PEG (5Y)4.73
Profitability
Industry RankSector Rank
ROA 0.63%
ROE N/A
ROCE 7.5%
ROIC 5.91%
ROICexc 5.96%
ROICexgc 9.8%
OM 19.77%
PM (TTM) 1.95%
GM 66.98%
FCFM N/A
ROA(3y)1.82%
ROA(5y)2.2%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)5.88%
ROIC(5y)5.9%
ROICexc(3y)5.95%
ROICexc(5y)5.98%
ROICexgc(3y)10.42%
ROICexgc(5y)10.9%
ROCE(3y)7.47%
ROCE(5y)7.49%
ROICexcg growth 3Y-1.19%
ROICexcg growth 5Y-0.22%
ROICexc growth 3Y1.92%
ROICexc growth 5Y3.27%
OM growth 3Y-0.58%
OM growth 5Y1.53%
PM growth 3Y-33.64%
PM growth 5Y-14.13%
GM growth 3Y-1.38%
GM growth 5Y3.37%
F-Score5
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA 6.58
Cap/Depr 234.82%
Cap/Sales 34.38%
Interest Coverage 1.62
Cash Conversion 58.62%
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.62
Altman-Z 1
F-Score5
WACC7.93%
ROIC/WACC0.74
Cap/Depr(3y)166.84%
Cap/Depr(5y)132%
Cap/Sales(3y)24%
Cap/Sales(5y)19.37%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-0.56%
EPS 3Y5.37%
EPS 5Y11.69%
EPS Q2Q%0%
EPS Next Y15.39%
EPS Next 2Y14.73%
EPS Next 3Y13.74%
EPS Next 5YN/A
Revenue 1Y (TTM)11.04%
Revenue growth 3Y11.04%
Revenue growth 5Y7.61%
Sales Q2Q%7.83%
Revenue Next Year10.57%
Revenue Next 2Y9.78%
Revenue Next 3Y8.96%
Revenue Next 5Y7.68%
EBIT growth 1Y8.81%
EBIT growth 3Y10.4%
EBIT growth 5Y9.25%
EBIT Next Year118.76%
EBIT Next 3Y36.63%
EBIT Next 5Y27.87%
FCF growth 1Y-6413.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y26.14%
OCF growth 3Y16.4%
OCF growth 5Y4.36%